Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 414

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 414
---
 3 March 2023 the Company advised Bioasis that it would offset this liability against the sums it advanced as disclosed in note 13.

As at 31 December 2023
and 31 December 2022 the Company had a contingent liability of $225,000 in relation to this potential liability.

| 28 | Ultimate controlling party |

The Directors do not
consider that there is an ultimate controlling party.

| 29 | Post Balance Sheet Events |

On 22 January 2024
membership of the Board Committees were changed to the following:

| Schedule of share consolidation |                 |                        |                       |
|                                 | Audit Committee | Remuneration Committee | Nominations Committee |
| Stephen Parker                  | X               |                        | X*                    |
| Sijmen de Vries                 |                 | X*                     | X                     |
| Ann Merchant                    | X               | X                      |                       |
| Simon Turton                    | X*              | X                      | X                     |
| *Chair of Committee             |                 |                        |                       |

| F-77 |

<div align='center'>PROSPECTUS

JANUARY 27, 2024</div>